National report - Dermatologists seem to be greeting calls for a single national registry for clinical drug trials with a collective shrug of their shoulders.
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Highlights from AAD 2023
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
New Technology Could Allow Us to Rethink Alopecia Scores
Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus